Anette Hardy-Sosa

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Minimally Invasive

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Dania Vázquez-Blomquist, Anette Hardy-Sosa, Saiyet C Baez, Vladimir Besada, Sucel Palomares, Osmany Guirola, Yassel Ramos, Jacek R Wiśniewski, Luis Javier González, Iraldo Bello-Rivero
Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. Cells 11 (24) (2022)
Dania Vázquez-Blomquist, Anette Hardy-Sosa, Saiyet C Baez, Vladimir Besada, Sucel Palomares, Osmany Guirola, Yassel Ramos, Jacek R Wiśniewski, Luis Javier González, Iraldo Bello-Rivero
Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. Cells 11 (24) (2022)
Dania Vázquez-Blomquist, Anette Hardy-Sosa, Saiyet C Baez, Vladimir Besada, Sucel Palomares, Osmany Guirola, Yassel Ramos, Jacek R Wiśniewski, Luis Javier González, Iraldo Bello-Rivero
Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. Cells 11 (24) (2022)
Dania Vázquez-Blomquist, Anette Hardy-Sosa, Saiyet C Baez, Vladimir Besada, Sucel Palomares, Osmany Guirola, Yassel Ramos, Jacek R Wiśniewski, Luis Javier González, Iraldo Bello-Rivero
Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. Cells 11 (24) (2022)
Dania Vázquez-Blomquist, Anette Hardy-Sosa, Saiyet C Baez, Vladimir Besada, Sucel Palomares, Osmany Guirola, Yassel Ramos, Jacek R Wiśniewski, Luis Javier González, Iraldo Bello-Rivero
Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. Cells 11 (24) (2022)